Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 6/2019

01-06-2019 | Metastasis | Colorectal Cancer

Response to Dr. Veld et al. Regarding the Manuscript Titled “What is the Best Option Between Primary Diverting Stoma or Endoscopic Stent as a Bridge to Surgery with a Curative Intent for Obstructed Left Colon Cancer? Results from a Propensity Score Analysis of the French Surgical Association Multicenter Cohort of 518 patients”

Authors: Diane Mege, MD, PhD, Charles Sabbagh, MD, PhD, Gilles Manceau, MD, PhD, Mehdi Karoui, MD, PhD

Published in: Annals of Surgical Oncology | Issue 6/2019

Login to get access

Excerpt

We read with great interest the comment on our paper by Veld et al. The use of endoscopic stent (ES) as a bridge to surgery, and its impact on survival, remains a matter of debate and a hot topic. Published data are contradictory, but several studies suggest a negative impact of ES on survival1,2; therefore, ES as a bridge to surgery is not recommended by the French and European guidelines.3,4 …
Literature
1.
Sabbagh C, Browet F, Diouf M, Cosse C, Brehant O, Bartoli E, et al. Is stenting as “a bridge to surgery” an oncologically safe strategy for the management of acute, left-sided, malignant, colonic obstruction? A comparative study with a propensity score analysis. Ann Surg. 2013;258:107–15.
2.
Sloothaak DA, van den Berg MW, Dijkgraaf MG, Fockens P, Tanis PJ, van Hooft JE, et al. Oncological outcome of malignant colonic obstruction in the Dutch Stent-In 2 trial. Br J Surg. 2014;101:1751–7.
3.
van Hooft JE, van Halsema EE, Vanbiervliet G, Beets-Tan RG, DeWitt JM, Donnellan F, et al. Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy. 2014;46:990–1053.
4.
Endoscopy and Cancer Committee of the French Society of Digestive Edoscopy (SFED) and the French Federation of Digestive Oncology (FFCD). Place of colorectal stents in therapeutic management of malignant large bowel obstructions. Endoscopy. 2014;46:546–52.
5.
van Hooft JE, Bemelman WA, Oldenburg B, Marinelli AW, Lutke Holzik MF, Grubben MJ, et al. Colonic stenting versus emergency surgery for acute left-sided malignant colonic obstruction: a multicentre randomised trial. Lancet Oncol. 2011;12:344–52.
6.
Pirlet IA, Slim K, Kwiatkowski F, Michot F, Millat BL. Emergency preoperative stenting versus surgery for acute left-sided malignant colonic obstruction: a multicenter randomized controlled trial. Surg Endosc. 2011;25:1814–21.
Metadata
Title
Response to Dr. Veld et al. Regarding the Manuscript Titled “What is the Best Option Between Primary Diverting Stoma or Endoscopic Stent as a Bridge to Surgery with a Curative Intent for Obstructed Left Colon Cancer? Results from a Propensity Score Analysis of the French Surgical Association Multicenter Cohort of 518 patients”
Authors
Diane Mege, MD, PhD
Charles Sabbagh, MD, PhD
Gilles Manceau, MD, PhD
Mehdi Karoui, MD, PhD
Publication date
01-06-2019
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 6/2019
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-019-07281-3

Other articles of this Issue 6/2019

Annals of Surgical Oncology 6/2019 Go to the issue

Hepatobiliary Tumors

Systematic Review of Surgical and Percutaneous Irreversible Electroporation in the Treatment of Locally Advanced Pancreatic Cancer

Hepatobiliary Tumors

Impact of Anatomical Versus Non-anatomical Liver Resection on Short- and Long-Term Outcomes for Patients with Intrahepatic Cholangiocarcinoma

Breast Oncology

Breast-Contour-Preserving Procedure as a Multidisciplinary Parameter of Esthetic Outcome in Breast Cancer Treatment in The Netherlands

Breast Oncology

Response to: “Intact Excision of Breast Lesions Using BLES™: Is There a Clinical Indication Yet?”

Gastrointestinal Oncology

Survival Benefit of Neoadjuvant Chemotherapy with S-1 Plus Docetaxel for Locally Advanced Gastric Cancer: A Propensity Score-Matched Analysis

Sarcoma

Raining Frogs, Flying Horses, and Defining Tumor Rupture in GIST